A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia.

Zawit, Misam; Gurnari, Carmelo; Pagliuca, Simona; Awada, Hassan; Maciejewski, Jaroslaw P; Saunthararajah, Yogen

Zawit, Misam; Gurnari, Carmelo; Pagliuca, Simona; Awada, Hassan; Maciejewski, Jaroslaw P; Saunthararajah, Yogen.

Afiliação

Zawit M; Translational Hematology and Oncology Research Department Taussig Cancer Center Cleveland Clinic Cleveland OH USA.
Gurnari C; Translational Hematology and Oncology Research Department Taussig Cancer Center Cleveland Clinic Cleveland OH USA.
Pagliuca S; Department of Biomedicine and Prevention & Ph.D in Immunology, Molecular Medicine and Applied Biotechnology University of Rome Tor Vergata Rome Italy.
Awada H; Translational Hematology and Oncology Research Department Taussig Cancer Center Cleveland Clinic Cleveland OH USA.
Maciejewski JP; Université de Paris Paris France.
Saunthararajah Y; Translational Hematology and Oncology Research Department Taussig Cancer Center Cleveland Clinic Cleveland OH USA.

Clin Case Rep ; 9(9): e04533, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34552731

Palavras-chave

Tcell large granular lymphocytic leukemia; decitabine; frail patients; noncytotoxic regimen

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article